当前位置: 首页 >> 检索结果
482. Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical Trial.
作者: Ye-Lin Liang.;Xu Liu.;Liang-Fang Shen.;Guang-Yuan Hu.;Guo-Rong Zou.;Ning Zhang.;Chuan-Ben Chen.;Xiao-Zhong Chen.;Xiao-Dong Zhu.;Ya-Wei Yuan.;Kun-Yu Yang.;Feng Jin.;Wei-Han Hu.;Fang-Yun Xie.;Ying Huang.;Fei Han.;Ling-Long Tang.;Yan-Ping Mao.;Li-Xia Lu.;Rui Sun.;Yu-Xiang He.;Yang-Ying Zhou.;Guo-Xian Long.;Jie Tang.;Lu-Si Chen.;Jing-Feng Zong.;Ting Jin.;Ling Li.;Jie Lin.;Jing Huang.;Xiu-Yun Gong.;Guan-Qun Zhou.;Lei Chen.;Wen-Fei Li.;Yu-Pei Chen.;Cheng Xu.;Li Lin.;Shao-Hui Huang.;Sai-Wei Huang.;Ya-Qin Wang.;Cheng-Long Huang.;Hui-Xia Feng.;Min Hou.;Chun-Hua Chen.;Su-Fen Zheng.;Ying-Qing Li.;Shu-Bin Hong.;Yu-Sheng Jie.;Hao Li.;Jing-Ping Yun.;Sheng-Bing Zang.;Song-Ran Liu.;Qing-Guang Lin.;Hao-Jiang Li.;Li Tian.;Li-Zhi Liu.;Hong-Yun Zhao.;Ji-Bin Li.;Ai-Hua Lin.;Na Liu.;Yuan Zhang.;Rui Guo.;Jun Ma.;Ying Sun.
来源: JAMA. 2025年333卷18期1589-1598页
Approximately 20% to 30% of patients with locoregionally advanced nasopharyngeal carcinoma (NPC) experience disease relapse despite definitive chemoradiotherapy. The programmed cell death 1 (PD-1) blockade camrelizumab has demonstrated considerable value in recurrent or metastatic NPC, while its role in locoregionally advanced NPC is unclear.
488. CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
作者: .;James D Berry.;Nicholas J Maragakis.;Eric A Macklin.;Lori B Chibnik.;Melanie Quintana.;Benjamin R Saville.;Michelle A Detry.;Matteo Vestrucci.;Joseph Marion.;Anna McGlothlin.;Elijah W Stommel.;Marianne Chase.;Lindsay Pothier.;Brittney A Harkey.;Hong Yu.;Alex Sherman.;Jeremy Shefner.;Meghan Hall.;Gale Kittle.;Suma Babu.;Jinsy Andrews.;Derek D'Agostino.;Eric Tustison.;Erica Scirocco.;Elisa Giacomelli.;Gustavo Alameda.;Eduardo Locatelli.;Doreen Ho.;Adam Quick.;Senda Ajroud-Driss.;Jonathan Katz.;Daragh Heitzman.;Stanley H Appel.;Sheetal Shroff.;Kevin J Felice.;Zachary Simmons.;Timothy Miller.;Nicholas Olney.;Michael D Weiss.;Stephen A Goutman.;Joseph Americo Fernandes.;Omar Jawdat.;Margaret Ayo Owegi.;Laura Foster.;Tuan Vu.;Hristelina Ilieva.;Daniel S Newman.;Ximena Arcila-Londono.;Carlayne Jackson.;Shafeeq Ladha.;Terry Heiman-Patterson.;James Caress.;Andrea Swenson.;Amanda Peltier.;Richard Lewis.;Dominic Fee.;Matthew Elliott.;Richard Bedlack.;Edward J Kasarskis.;Lauren Elman.;Jeffrey Rosenfeld.;David Walk.;Courtney E McIlduff.;Paul Twydell.;Eufrosina Young.;Kristin Johnson.;Kourosh Rezania.;Namita A Goyal.;Jeffrey A Cohen.;Michael Benatar.;Vovanti Jones.;Jonathan Glass.;Jaimin Shah.;Said R Beydoun.;James P Wymer.;Lindsay Zilliox.;Shakti Nayar.;Gary L Pattee.;Jennifer Martinez-Thompson.;Austin Rynders.;Jacob Evan.;Jeremy Evan.;Alan Hartford.;Marjan Sepassi.;Karen S Ho.;Robert Glanzman.;Benjamin Greenberg.;Michael T Hotchkin.;Sabrina Paganoni.;Merit E Cudkowicz.; .
来源: JAMA. 2025年333卷13期1138-49页
Bioenergetic failure has been proposed as a driver of amyotrophic lateral sclerosis (ALS). CNM-Au8 is a suspension of gold nanocrystals that catalyzes the conversion of nicotinamide adenine dinucleotide hydride into NAD+, resulting in an increase of cellular adenosine triphosphate production.
489. Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
作者: .;Jeremy M Shefner.;Björn Oskarsson.;Eric A Macklin.;Lori B Chibnik.;Melanie Quintana.;Benjamin R Saville.;Michelle A Detry.;Matteo Vestrucci.;Joe Marion.;Anna McGlothlin.;Terry Heiman-Patterson.;Marianne Chase.;Lindsay Pothier.;Brittney A Harkey.;Hong Yu.;Alexander V Sherman.;Meghan Hall.;Gale Kittle.;James D Berry.;Suma Babu.;Jinsy Andrews.;Derek D'Agostino.;Eric Tustison.;Erica Scirocco.;Elisa Giacomelli.;Gustavo Alameda.;Eduardo Locatelli.;Doreen Ho.;Adam Quick.;Senda Ajroud-Driss.;Jonathan Katz.;Daragh Heitzman.;Stanley H Appel.;Sheetal Shroff.;Kevin Felice.;Nicholas J Maragakis.;Zachary Simmons.;Timothy M Miller.;Nicholas Olney.;Michael D Weiss.;Stephen A Goutman.;Joseph Americo Fernandes.;Omar Jawdat.;Margaret Ayo Owegi.;Laura A Foster.;Tuan Vu.;Hristelina Ilieva.;Daniel S Newman.;Ximena Arcila-Londono.;Carlayne E Jackson.;Shafeeq Ladha.;James B Caress.;Andrea Swenson.;Amanda Peltier.;Richard A Lewis.;Dominic Fee.;Matthew Elliott.;Richard Bedlack.;Edward J Kasarskis.;Lauren Elman.;Jeffrey Rosenfeld.;David Walk.;Courtney McIlduff.;Paul Twydell.;Eufrosina Young.;Kristin Johnson.;Kourosh Rezania.;Namita A Goyal.;Jeffrey A Cohen.;Michael Benatar.;Vovanti Jones.;Jaimin Shah.;Said R Beydoun.;James P Wymer.;Lindsay Zilliox.;Shakti Nayar.;Gary L Pattee.;Jennifer Martinez-Thompson.;Melanie L Leitner.;Kelly Chen.;Y Paul Goldberg.;Yael Cohen.;Michal Geva.;Michael R Hayden.;Sabrina Paganoni.;Merit E Cudkowicz.; .
来源: JAMA. 2025年333卷13期1128-37页
Amyotrophic lateral sclerosis (ALS) is a fatal disease. The sigma-1 (σ1) receptor emerged as a target for intervention.
491. Screening for Food Insecurity: US Preventive Services Task Force Recommendation Statement.
作者: .;Wanda K Nicholson.;Michael Silverstein.;John B Wong.;David Chelmow.;Tumaini Rucker Coker.;Alicia Fernandez.;Ericka Gibson.;Carlos Roberto Jaén.;Marie Krousel-Wood.;Sei Lee.;Goutham Rao.;John M Ruiz.;James Stevermer.;Joel Tsevat.;Sandra Millon Underwood.;Sarah Wiehe.
来源: JAMA. 2025年333卷15期1333-1339页
According to survey data, 12.8% of households experienced food insecurity in 2022, with 7.7% of households experiencing low food security and 5.1% experiencing very low food security. Nearly one-third of households with incomes below the federal poverty threshold are food insecure. Food insecurity is one among a multitude of medical, psychological, and social conditions common among economically disadvantaged households.
495. Preventive Services for Food Insecurity: Evidence Report and Systematic Review for the US Preventive Services Task Force.
作者: Elizabeth A O'Connor.;Elizabeth M Webber.;Allea M Martin.;Michelle L Henninger.;Michelle L Eder.;Jennifer S Lin.
来源: JAMA. 2025年333卷15期1340-1351页
An estimated 12.8% of US households experienced food insecurity in 2022.
496. Prostate Cancer: A Review.
Prostate cancer is the most common nonskin cancer in men in the US, with an estimated 299 010 new cases and 35 250 deaths in 2024. Prostate cancer is the second most common cancer in men worldwide, with 1 466 680 new cases and 396 792 deaths in 2022.
498. High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial.
作者: Eric Thouvenot.;David Laplaud.;Christine Lebrun-Frenay.;Nathalie Derache.;Emmanuelle Le Page.;Elisabeth Maillart.;Caroline Froment-Tilikete.;Giovanni Castelnovo.;Olivier Casez.;Marc Coustans.;Anne-Marie Guennoc.;Olivier Heinzlef.;Laurent Magy.;Chantal Nifle.;Xavier Ayrignac.;Agnès Fromont.;Nicolas Gaillard.;Nathalie Caucheteux.;Ivania Patry.;Jérôme De Sèze.;Romain Deschamps.;Pierre Clavelou.;Damien Biotti.;Gilles Edan.;William Camu.;Hanane Agherbi.;Dimitri Renard.;Christophe Demattei.;Pascale Fabbro-Peray.;Thibault Mura.;Manon Rival.; .
来源: JAMA. 2025年333卷16期1413-1422页
Vitamin D deficiency is a risk factor for multiple sclerosis (MS) and is associated with the risk of disease activity, but data on the benefits of supplementation are conflicting.
|